Opportunity Information: Apply for CDC RFA GH13 13020401SUPP16
Apply for CDC RFA GH13 13020401SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
- This funding opportunity was created on Aug 05, 2016.
- Applicants must submit their applications by Oct 05, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cooperative Agreement on Immunization with the United Nations Children's Fund (UNICEF) is a CDC-run, congressionally funded grant opportunity designed to help finance and coordinate vaccine procurement and on-the-ground immunization support for major global disease-control efforts. The funding is routed through the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under a cooperative agreement mechanism (Funding Opportunity Number CDC RFA GH13 13020401SUPP16; CFDA 93.185). It sits within the global health space and is structured to support internationally agreed goals around eradicating polio, reducing and eliminating measles, and strengthening broader immunization systems in developing countries.
At its core, the program exists because the U.S. Congress provides CDC with funds specifically intended to ensure that vaccines and related program support are available for large-scale global immunization initiatives. The opportunity explicitly aligns with U.S. Government-endorsed efforts, including the Global Polio Eradication Initiative, the Global Measles Initiative, and the Global Immunization Vision and Strategy (GIVS). UNICEF is positioned as a central implementing partner, working closely with CDC, and coordinating with other major global and regional health actors such as the World Health Organization (WHO), the Pan American Health Organization (PAHO), Rotary International, the American Red Cross, and the UN Foundation. National governments in priority countries are also part of the implementation ecosystem, since the work ultimately supports country immunization goals and delivery systems.
The practical aim of the cooperative agreement is twofold. First, it supports supplemental immunization activities (SIAs), which are typically time-bound, high-intensity campaigns meant to rapidly increase population immunity in targeted age groups or geographic areas, especially where routine services have gaps or where outbreaks and transmission risks remain high. Second, it invests in strengthening routine immunization delivery systems and country capacity so that immunization gains are sustained over time, rather than relying only on periodic campaigns. While polio and measles are the primary focus, the award also allows flexibility to support other global health priorities that fit CDC goals, including control of other vaccine-preventable diseases (VPDs) when strategically appropriate.
UNICEF's role under this agreement centers on using its established vaccine procurement and distribution platforms to get quality-assured vaccines to the countries that need them most. The description emphasizes that vaccines delivered through UNICEF systems must meet WHO or national quality specifications, reflecting the program's intent to pair scale with safety and quality control. Beyond procurement, UNICEF is expected to collaborate with CDC, WHO, Rotary, other partners, and national governments to identify and prioritize where vaccine supplies and programmatic support are most urgently needed. This includes assessing country requests and gaps, helping set priorities among competing needs, and aligning support with eradication and elimination strategies agreed to globally.
The activities funded through the cooperative agreement include allocating money for vaccine procurement (noted as the majority share of total funds), as well as providing technical assistance in partnership with CDC and WHO. That technical support is framed around the real operational components that determine whether vaccines actually reach children and are successfully administered: vaccine supply and logistics, cold chain systems to keep vaccines at correct temperatures from arrival to point of use, planning and implementation support for immunization activities, communications and social mobilization to increase demand and address hesitancy or access barriers, and training to strengthen the workforce delivering immunization services. Taken together, the grant is designed to pay for both the product (vaccines) and the enabling infrastructure and expertise needed to deliver those vaccines effectively in priority settings.
Administratively, the opportunity is categorized as a discretionary cooperative agreement in the health activity category, with an expected single award (ExpectedAwards: 1). The source data lists an award ceiling of 0, which typically indicates that a specific ceiling was not stated in the public synopsis or is handled through other award documentation. The notice was created August 5, 2016, with an original closing date of October 5, 2016, and it specifies that electronic submissions were due by 11:59 p.m. Eastern Time on the application deadline. Eligibility is listed broadly as "Others," with additional eligibility details referenced in the full announcement text, which is common for opportunities that are effectively intended for a specific entity or a narrow class of organizations with a unique role (in this case, UNICEF as the named partner).
Overall, this grant opportunity functions as a financing and coordination vehicle that leverages UNICEF's procurement reach and in-country operational footprint, combined with CDC and WHO technical leadership and multi-partner collaboration, to push forward polio eradication, measles mortality reduction and elimination, and wider vaccine-preventable disease control. The emphasis on vaccine procurement as the dominant cost reflects the scale of immunization needs, while the included support for logistics, cold chain, communications, and training recognizes that successful immunization outcomes depend just as much on delivery systems as on vaccine supply.
Frequently Asked Questions (FAQs)
What is the Cooperative Agreement on Immunization with UNICEF?
It is a CDC-run, congressionally funded grant opportunity structured as a cooperative agreement to help finance and coordinate vaccine procurement and on-the-ground immunization support for major global disease-control efforts. The work is implemented through the United Nations Children's Fund (UNICEF) in collaboration with CDC and other partners.
Which agency is offering and administering this opportunity?
The funding is routed through the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), under a cooperative agreement mechanism.
What is the funding mechanism and program identification information?
The mechanism is a discretionary cooperative agreement in the health activity category. The Funding Opportunity Number is CDC RFA GH13 13020401SUPP16, and the CFDA number is 93.185.
What is the main purpose of the cooperative agreement?
The agreement is designed to ensure that vaccines and related program support are available for large-scale global immunization initiatives. It combines financing for vaccine procurement with support that helps countries deliver vaccines effectively.
Which global health goals and initiatives does this opportunity align with?
The opportunity explicitly aligns with U.S. Government-endorsed efforts, including the Global Polio Eradication Initiative, the Global Measles Initiative, and the Global Immunization Vision and Strategy (GIVS).
Which diseases are the primary focus of the work?
Polio eradication and measles mortality reduction and elimination are the primary focus areas described for this cooperative agreement.
Can the award support other vaccine-preventable diseases besides polio and measles?
Yes. While polio and measles are the core priorities, the description indicates flexibility to support other global health priorities that fit CDC goals, including control of other vaccine-preventable diseases when strategically appropriate.
What are Supplemental Immunization Activities (SIAs) in the context of this grant?
SIAs are time-bound, high-intensity immunization campaigns intended to rapidly increase population immunity in targeted age groups or geographic areas, particularly where routine immunization has gaps or where outbreak and transmission risks remain high.
How does the program support routine immunization, not just campaigns?
In addition to SIAs, the cooperative agreement invests in strengthening routine immunization delivery systems and country capacity so immunization gains are sustained over time rather than relying solely on periodic campaigns.
What is UNICEF's role under this cooperative agreement?
UNICEF serves as the central implementing partner, using its established vaccine procurement and distribution platforms to supply vaccines and coordinating with CDC and other partners to prioritize needs and support immunization activities in developing countries.
What is CDC's role relative to UNICEF under this cooperative agreement?
CDC funds and oversees the work under a cooperative agreement framework and works closely with UNICEF, including partnering on technical assistance and aligning activities with agreed global eradication and elimination strategies.
Which other organizations are mentioned as partners or collaborators?
The description references coordination with major global and regional health actors such as the World Health Organization (WHO), the Pan American Health Organization (PAHO), Rotary International, the American Red Cross, and the UN Foundation, along with national governments in priority countries.
Why are national governments involved?
National governments are part of the implementation ecosystem because the activities ultimately support country immunization goals and the delivery systems that administer vaccines to communities.
What types of activities and costs are funded?
Funded activities include allocating money for vaccine procurement (described as the majority share of total funds) and providing technical assistance related to delivering vaccines effectively in the field.
Is vaccine procurement expected to be the largest use of funds?
Yes. The opportunity states that vaccine procurement represents the majority share of the total funds, reflecting the scale of vaccine needs in large global immunization initiatives.
What kinds of technical assistance are included?
Technical assistance is described around practical operational components such as vaccine supply and logistics, cold chain systems, planning and implementation support for immunization activities, communications and social mobilization, and training to strengthen the immunization workforce.
What does "cold chain" refer to in this opportunity?
Cold chain refers to systems that keep vaccines at the correct temperatures from arrival in-country through distribution to the point of use, supporting vaccine quality and effectiveness during delivery.
How does the cooperative agreement address demand or hesitancy issues?
The description includes communications and social mobilization as funded support areas to increase demand and address barriers such as hesitancy or access challenges.
Are there quality requirements for vaccines procured and delivered through UNICEF?
Yes. Vaccines delivered through UNICEF systems are expected to meet WHO or national quality specifications, reflecting an emphasis on safety and quality assurance alongside scale.
How are priorities determined for where vaccines and support go?
UNICEF, in collaboration with CDC, WHO, Rotary, other partners, and national governments, is expected to identify and prioritize where vaccine supplies and programmatic support are most urgently needed. This includes assessing country requests and gaps and setting priorities among competing needs.
How does this cooperative agreement strengthen long-term immunization capacity?
By investing in routine immunization delivery systems and country capacity (including logistics, cold chain, workforce training, and planning support), the program aims to sustain gains beyond short-term campaigns.
How many awards are expected to be made?
The source information lists an expected single award (ExpectedAwards: 1).
What is the award ceiling for this opportunity?
The source data lists an award ceiling of 0, which typically indicates that a specific ceiling was not stated in the public synopsis or is addressed in other award documentation.
When was the notice created and what were the application dates?
The notice was created on August 5, 2016. The original closing date was October 5, 2016.
What was the application submission deadline time and time zone?
Electronic submissions were due by 11:59 p.m. Eastern Time on the application deadline.
Who is eligible to apply based on the information provided?
Eligibility is listed broadly as "Others," with additional eligibility details referenced in the full announcement text. The description notes this is common when an opportunity is effectively intended for a specific entity or narrow class of organizations with a unique role (here, UNICEF is the named partner).
Is this opportunity focused on developing countries?
Yes. The description emphasizes strengthening immunization systems and delivering vaccines in developing countries, with national governments in priority countries involved in implementation.
What makes this opportunity a "cooperative agreement" rather than a standard grant?
Based on the information provided, it is explicitly described as a cooperative agreement mechanism, which commonly implies a more collaborative relationship between the funder (CDC) and the implementing partner (UNICEF) in carrying out the supported activities.
What is the overall value of this cooperative agreement in global immunization efforts?
It functions as a financing and coordination vehicle that leverages UNICEF's procurement reach and operational footprint along with CDC and WHO technical leadership and multi-partner collaboration to advance polio eradication, measles reduction and elimination, and broader vaccine-preventable disease control.
Browse more opportunities from the same category: Health
Next opportunity: Notice of Intent: Using Technology to Bring Parks to People
Previous opportunity: Sound and Light Ecology Research
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 13020401SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 13020401SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1753 Funding Number: CDC RFA GH17 1753 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $200,000,000 |
| Building the Capacity of the Government of Suriname to Address Gaps in the HIV Continuum of Care for Key Populations and People Living with HIV (PLHIV) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1774 Funding Number: CDC RFA GH17 1774 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $300,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520501SUPP16 Funding Number: CDC RFA GH11 11520501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,604,705 |
| Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1721 Funding Number: CDC RFA GH17 1721 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $465,000 |
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
| Program Expansion Supplement: Scaling up Voluntary Medical Male Circumcision through improvement in HIV prevention under PEPFAR Apply for CDC RFA GH13 13280401SUPP16 Funding Number: CDC RFA GH13 13280401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,000,000 |
| Human Heredity and Health in Africa (H3Africa): Coordinating Center (U24) Apply for RFA RM 16 017 Funding Number: RFA RM 16 017 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $400,000 |
| Human Heredity and Health in Africa (H3Africa): Informatics Network (U24) Apply for RFA RM 16 011 Funding Number: RFA RM 16 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Vector Control Strategies- Enhancing Capacity for Vector Surveillance and Control to Prevent Zika, Dengue and Chikungunya Infection in Puerto Rico - Financed in part by Prevention and Public Health Funds Apply for CDC RFA CK16 1608PPHF2016 Funding Number: CDC RFA CK16 1608PPHF2016 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 15050104SUPP16 Funding Number: CDC RFA CK15 15050104SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: Case Dependent |
| Assist the Ministry of Health to Provide Critical Human Resources for Health to Achieve HIV Epidemic Control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1715 Funding Number: CDC RFA GH17 1715 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| Support for the National Blood Bank Services in the Implementation and Expansion of Blood Safety Activities in Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1746 Funding Number: CDC RFA GH17 1746 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,650,000 |
| Strengthening Capacity of HIV/AIDS Treatment in Ukraine under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1761 Funding Number: CDC RFA GH17 1761 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,600,000 |
| Enhancing Sustainable and Integrated Health, Strategic Information and Laboratory Systems for Quality Comprehensive HIV Services through Technical Assistance to the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1750 Funding Number: CDC RFA GH17 1750 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $720,000 |
| Strengthening Local Ownership and Sustainable Provision of Quality Comprehensive HIV/AIDS Services for Inmates in the Federal Prison Administration (FPA) and Regional Prisons of Ethiopia under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1777 Funding Number: CDC RFA GH17 1777 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Hypertension Outcomes for T4 REsearch within Lower Middle-Income Countries (Hy-TREC) (U01) Apply for RFA HL 17 014 Funding Number: RFA HL 17 014 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $268,500 |
| USAID’s Improving Nutrition through Community-based Approaches (INCA) Activity Apply for RFA 388 16 000010 Funding Number: RFA 388 16 000010 Agency: Agency for International Development, Bangladesh USAID-Dhaka Category: Health Funding Amount: $4,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 13020401SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.